The low-risk group included 72% of the TSC1 mutation (28 of 39 TSC1 mutations) or 67% of the ERBB3 mutation (30 of 45 ERBB3 mutations) in bladder cancer (Table 8 and Table 9). Here, ERBB3 is linked to urinary bladder cancer.